| Identification | Back Directory | [Name]
Deacetyl ganoderic acid F | [CAS]
100665-44-9 | [Synonyms]
Deacetyl ganoderic acid F
Ganoderic acid F, deacetyl-
12β-hydroxy-3,7,11,15,23-pentaoxo-5α-lanost-8-en-26-oicaci
(12beta)-12-Hydroxy-3,7,11,15,23-pentaoxolanost-8-en-26-oic acid
Lanost-8-en-26-oic acid, 12-hydroxy-3,7,11,15,23-pentaoxo-, (12β)- | [Molecular Formula]
C30 H40 O8 | [MDL Number]
MFCD29917901 | [MOL File]
100665-44-9.mol | [Molecular Weight]
528.63 |
| Chemical Properties | Back Directory | [Boiling point ]
707.9±60.0 °C(Predicted) | [density ]
1.26±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
Powder | [pka]
4.77±0.23(Predicted) |
| Hazard Information | Back Directory | [Description]
Deacetyl ganoderic acid F (DeGA F) is a triterpenoid isolated from Ganoderma lucidum, which is a famous edible and medicinal mushroom used for treatment of dizziness and insomnia in traditional medicine for a long time. In vitro studies have shown that DeGA F has significant anti-inflammatory effects, and the modulation of the NF-κB pathway may be the main mechanism for the anti-inflammatory effects of DeGA F. In addition, DeGA F also inhibited LPS-induced NF-κB activation in mouse brain, which has potential therapeutic effects on neuroinflammation-related diseases. | [storage]
Store at -20°C |
|
|